Pembrolizumab + Imprime PGG for Metastatic Non-small Cell Lung Cancer After Progression on First-Line Therapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017
Clinical trial NCT03003468 · COMPLETED
Trial details
- NCT number
- NCT03003468
- Sponsor
- Lawrence Feldman, MD
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-11
- Primary completion
- 2021-11-22
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.